|
1
|
Wolf A, Bray GA and Popkin BM: A short
history of beverages and how our body treats them. Obes Rev.
9:151–164. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
A B. Beling A Jahresbericht_2015 n.d.;
250516. Lay.
|
|
3
|
Fujioka K, Iwamoto T, Shima H, Tomaru K,
Saito H, Ohtsuka M, Yoshidome A, Kawamura Y and Manome Y: The
powdering process with a set of ceramic mills for green tea
promoted catechin extraction and the ROS inhibition effect.
Molecules. 21:4742016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cabrera C, Artacho R and Giménez R:
Beneficial effects of green tea: a review. J Am Coll Nutr.
25:79–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tachibana H: Molecular basis for cancer
chemoprevention by green tea polyphenol EGCG. Forum Nutr.
61:156–169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Belitz HD, Grosch W and Schieberle P: Food
Chemistry 4th edition. Springer-Verlag Berlin Heidelberg.
https://doi.org/10.1007/978-3-40-69934-7
|
|
7
|
Stangl V, Lorenz M and Stangl K: The role
of tea and tea flavonoids in cardiovascular health. Mol Nutr Food
Res. 50:218–228. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhagwat S, Haytowitz DB and Holden JM:
USDA Database for the Flavonoid Content of Selected Foods.
2011.
|
|
9
|
Hallman K, Aleck K, Quigley M, Dwyer B,
Lloyd V, Szmyd M and Dinda S: The regulation of steroid receptors
by epigallocatechin-3-gallate in breast cancer cells. Breast Cancer
(Dove Med Press). 9:365–373. 2017.PubMed/NCBI
|
|
10
|
Wu M, Liu D, Zeng R, Xian T, Lu Y, Zeng G,
Sun Z, Huang B and Huang Q: Epigallocatechin-3-gallate inhibits
adipogenesis through down-regulation of PPARγ and FAS expression
mediated by PI3K-AKT signaling in 3T3-L1 cells. Eur J Pharmacol.
795:134–142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ding ML, Ma H, Man YG and Lv HY:
Protective effects of a green tea polyphenol,
epigallocatechin-3-gallate, against sevoflurane-induced neuronal
apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/Akt/mTOR
signalling pathways in neonatal mice. Can J Physiol Pharmacol.
95:1396–1405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rashidi B, Malekzadeh M, Goodarzi M,
Masoudifar A and Mirzaei H: Green tea and its anti-angiogenesis
effects. Biomed Pharmacother. 89:949–956. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li YF, Wang H, Fan Y, Shi HJ, Wang QM,
Chen BR, Khurwolah MR, Long QQ, Wang SB, Wang ZM, et al:
Epigallocatechin-3-gallate inhibits matrix metalloproteinase-9 and
monocyte chemotactic protein-1 expression through the 67-kDa
laminin receptor and the TLR4/MAPK/NF-κB signalling pathway in
lipopolysaccharide-induced macrophages. Cell Physiol Biochem.
43:926–936. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moradzadeh M, Hosseini A, Erfanian S and
Rezaei H: Epigallocatechin-3-gallate promotes apoptosis in human
breast cancer T47D cells through down-regulation of PI3K/AKT and
Telomerase. Pharmacol Rep. 69:924–928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang CY, Han Z, Li X, Xie HH and Zhu SS:
Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human
breast cancer. Oncol Lett. 14:3623–3627. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
S3 Leitlinie Mammakarzinom: n.d.
https://www.awmf.org/uploads/tx_szleitlinien/032-045OLl_S3_Mammakarzinom_2018-09.pdf
|
|
17
|
Thangapazham RL, Singh AK, Sharma A,
Warren J, Gaddipati JP and Maheshwari RK: Green tea polyphenols and
its constituent epigallocatechin gallate inhibits proliferation of
human breast cancer cells in vitro and in vivo. Cancer Lett.
245:232–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang P, Henning SM and Heber D:
Limitations of MTT and MTS-based assays for measurement of
antiproliferative activity of green tea polyphenols. PLoS One.
5:e102022010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu QY, Zhang A, Tsang D, Huang Y and Chen
Z-Y: Stability of Green Tea Catechins. J Agric Food Chem.
45:4624–4628. 1997. View Article : Google Scholar
|
|
20
|
Van Aller GS, Carson JD, Tang W, Peng H,
Zhao L, Copeland RA, Tummino PJ and Luo L: Epigallocatechin gallate
(EGCG), a major component of green tea, is a dual
phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res
Commun. 406:194–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bruning A: Inhibition of mTOR signaling by
quercetin in cancer treatment and prevention. Anticancer Agents Med
Chem. 13:1025–1031. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gu JW, Makey KL, Tucker KB, Chinchar E,
Mao X, Pei I, Thomas EY and Miele L: EGCG, a major green tea
catechin suppresses breast tumor angiogenesis and growth via
inhibiting the activation of HIF-1α and NF-κB, and VEGF expression.
Vasc Cell. 5:92013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang P, Vadgama JV, Said JW, Magyar CE,
Doan N, Heber D and Henning SM: Enhanced inhibition of prostate
cancer xenograft tumor growth by combining quercetin and green tea.
J Nutr Biochem. 25:73–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scandlyn MJ, Stuart EC, Somers-Edgar TJ,
Menzies AR and Rosengren RJ: A new role for tamoxifen in oestrogen
receptor-negative breast cancer when it is combined with
epigallocatechin gallate. Br J Cancer. 99:1056–1063. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Umeda D, Yano S, Yamada K and Tachibana H:
Green tea polyphenol epigallocatechin-3-gallate signaling pathway
through 67-kDa laminin receptor. J Biol Chem. 283:3050–3058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tachibana H, Koga K, Fujimura Y and Yamada
K: A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol.
11:380–381. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nelson J, McFerran NV, Pivato G, Chambers
E, Doherty C, Steele D and Timson DJ: The 67 kDa laminin receptor:
Structure, function and role in disease. Biosci Rep. 28:33–48.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mittal A, Pate MS, Wylie RC, Tollefsbol TO
and Katiyar SK: EGCG down-regulates telomerase in human breast
carcinoma MCF-7 cells, leading to suppression of cell viability and
induction of apoptosis. Int J Oncol. 24:703–710. 2004.PubMed/NCBI
|
|
29
|
Roy AM, Baliga MS and Katiyar SK:
Epigallocatechin-3-gallate induces apoptosis in estrogen
receptor-negative human breast carcinoma cells via modulation in
protein expression of p53 and Bax and caspase-3 activation. Mol
Cancer Ther. 4:81–90. 2005.PubMed/NCBI
|
|
30
|
Madeira M, Mattar A, Logullo ÂF, Soares FA
and Gebrim LH: Estrogen receptor alpha/beta ratio and estrogen
receptor beta as predictors of endocrine therapy responsiveness-a
randomized neoadjuvant trial comparison between anastrozole and
tamoxifen for the treatment of postmenopausal breast cancer. BMC
Cancer. 13:4252013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stuart EC, Scandlyn MJ and Rosengren RJ:
Role of epigallocatechin gallate (EGCG) in the treatment of breast
and prostate cancer. Life Sci. 79:2329–2336. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bruggisser R, von Daeniken K, Jundt G,
Schaffner W and Tullberg-Reinert H: Interference of plant extracts,
phytoestrogens and antioxidants with the MTT tetrazolium assay.
Planta Med. 68:445–448. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Scambia G, Ranelletti FO, Panici PB,
Piantelli M, De Vincenzo R, Ferrandina G, Bonanno G, Capelli A and
Mancuso S: Quercetin induces type-II estrogen-binding sites in
estrogen-receptor-negative (MDA-MB231) and
estrogen-receptor-positive (MCF-7) human breast-cancer cell lines.
Int J Cancer. 54:462–466. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee YK, Hwang JT, Kwon DY, Surh YJ and
Park OJ: Induction of apoptosis by quercetin is mediated through
AMPKalpha1/ASK1/p38 pathway. Cancer Lett. 292:228–236. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Duo J, Ying GG, Wang GW and Zhang L:
Quercetin inhibits human breast cancer cell proliferation and
induces apoptosis via Bcl-2 and Bax regulation. Mol Med Rep.
5:1453–1456. 2012.PubMed/NCBI
|
|
36
|
Klappan AK, Hones S, Mylonas I and Brüning
A: Proteasome inhibition by quercetin triggers macroautophagy and
blocks mTOR activity. Histochem Cell Biol. 137:25–36. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sang S, Lee MJ, Hou Z, Ho CT and Yang CS:
Stability of tea polyphenol (−)-epigallocatechin-3-gallate and
formation of dimers and epimers under common experimental
conditions. J Agric Food Chem. 53:9478–9484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang CS, Chen L, Lee MJ, Balentine D, Kuo
MC and Schantz SP: Blood and urine levels of tea catechins after
ingestion of different amounts of green tea by human volunteers.
Cancer Epidemiol Biomarkers Prev. 7:351–354. 1998.PubMed/NCBI
|
|
39
|
Chow HHS, Cai Y, Alberts DS, Hakim I, Dorr
R, Shahi F, Crowell JA, Yang CS and Hara Y: Phase I pharmacokinetic
study of tea polyphenols following single-dose administration of
epigallocatechin gallate and polyphenon E. Cancer Epidemiol
Biomarkers Prev. 10:53–58. 2001.PubMed/NCBI
|
|
40
|
Landis-Piwowar KR, Huo C, Chen D, Milacic
V, Shi G, Chan TH and Dou QP: A novel prodrug of the green tea
polyphenol (−)-epigallocatechin-3-gallate as a potential anticancer
agent. Cancer Res. 67:4303–4310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Landis-Piwowar KR, Wan SB, Wiegand RA,
Kuhn DJ, Chan TH and Dou QP: Methylation suppresses the
proteasome-inhibitory function of green tea polyphenols. J Cell
Physiol. 213:252–260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu AH, Tseng CC, Van Den Berg D and Yu MC:
Tea intake, COMT genotype, and breast cancer in Asian-American
women. Cancer Res. 63:7526–7529. 2003.PubMed/NCBI
|
|
43
|
Landis-Piwowar K, Chen D, Chan TH and Dou
QP: Inhibition of catechol-Omicron-methyltransferase activity in
human breast cancer cells enhances the biological effect of the
green tea polyphenol (−)-EGCG. Oncol Rep. 24:563–569.
2010.PubMed/NCBI
|
|
44
|
Miyazawa T: Absorption, metabolism and
antioxidative effects of tea catechin in humans. Biofactors.
13:55–59. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schönthal AH: Adverse effects of
concentrated green tea extracts. Mol Nutr Food Res. 55:874–885.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chisholm K, Bray BJ and Rosengren RJ:
Tamoxifen and epigallocatechin gallate are synergistically
cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer
Drugs. 15:889–897. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sakata M, Ikeda T, Imoto S, Jinno H and
Kitagawa Y: Prevention of mammary carcinogenesis in C3H/OuJ mice by
green tea and tamoxifen. Asian Pac J Cancer Prev. 12:567–571.
2011.PubMed/NCBI
|
|
48
|
Peng L, Wang B and Ren P: Reduction of MTT
by flavonoids in the absence of cells. Colloids Surf B
Biointerfaces. 45:108–111. 2005. View Article : Google Scholar : PubMed/NCBI
|
